Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic TargetingYam Nath Paudel, Mohd. Farooq Shaikh, Efthalia Angelopoulou et al.|Cells|2020Cited by 257
Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signallingYam Nath Paudel, Mohd. Farooq Shaikh, Efthalia Angelopoulou et al.|European Journal of Pharmacology|2019Cited by 175
Emerging neuroprotective effect of metformin in Parkinson’s disease: A molecular crosstalkYam Nath Paudel, Iekhsan Othman, Efthalia Angelopoulou et al.|Pharmacological Research|2019Cited by 118
HMGB1-Mediated Neuroinflammatory Responses in Brain Injuries: Potential Mechanisms and Therapeutic OpportunitiesYam Nath Paudel, Mohd. Farooq Shaikh, Efthalia Angelopoulou et al.|International Journal of Molecular Sciences|2020Cited by 113
Potential Neuroprotective Effect of the HMGB1 Inhibitor Glycyrrhizin in Neurological DisordersYam Nath Paudel, Mohd. Farooq Shaikh, Efthalia Angelopoulou et al.|ACS Chemical Neuroscience|2020Cited by 105